Previous Article | Next Article ![]()
Journal of Clinical Microbiology, October 2003, p. 4796-4798, Vol. 41, No. 10
0095-1137/03/$08.00+0 DOI: 10.1128/JCM.41.10.4796-4798.2003
Copyright © 2003, American Society for Microbiology. All Rights Reserved.
Sanquin Blood Bank North West Region,1 Department of Medical Microbiology and Infection Control, VU University Medical Center Amsterdam, Amsterdam, The Netherlands2
Received 1 April 2003/ Returned for modification 19 May 2003/ Accepted 5 July 2003
|
|
|---|
|
|
|---|
Two different isolation methods were used to prepare template DNA from PCs: a fully automated method with the MagNA Pure LC instrument (Total Nucleic Acid isolation kit, Roche Diagnostics) (8) and a manual extraction procedure with the NucliSens extraction kit (bioMérieux) (2, 14). Two strategies to reduce contaminating DNA in real-time PCR amplification were evaluated and found to be suited to meet the requirements of the PCR system to detect bacteria in PCs without affecting the high sensitivity of the assay.
To determine the detection limit of the assay, 1 ml of PCs was spiked with 100 µl of serial dilutions of Escherichia coli. The number of bacteria added to the PCs ranged from 10 to 20,000 CFU/ml. DNA was subsequently extracted from these spiked PCs using both the MagNA Pure LC instrument and the NucliSens extraction manual method.
In the MagNA Pure method, DNA was extracted from a 200-µl aliquot of spiked material and eluted in a final volume of 50 µl. In the NucliSens method, DNA was purified from a 2,000-µl aliquot of spiked PCs and eluted in a final volume of 50 µl. In addition, DNA was extracted from serial dilutions of a pure culture of E. coli by the same MagNA Pure extraction procedure.
A 466-bp fragment of the bacterial 16S ribosomal DNA was amplified using the forward primer 5'-TCCTACGGGAGGCAGCAGT-3', the reverse primer 5'-GGACTACCAGGGTATCTAATCCTGTT-3', and the probe (6-FAM)-5'-CGTATTACCGCGGCTGCTGGCAC-3'-(TAMRA) (12).
The PCRs were performed in a total volume of 25 µl using the TaqMan Universal PCR Master Mix on the ABI 7700 sequence detection system (Applied Biosystems). The reactions comprised 900 nM (each) forward and reverse primers, 200 nM probe, and 5 µl of template DNA. Negative controls (unspiked PCs) were included throughout the procedure. No-template controls (NTC) with water instead of template DNA were incorporated in each run under the following conditions: 50°C for 2 min, 95°C for 10 min, and 40 cycles of 95°C for 15 min and 60°C for 1 min.
The result of each PCR is indicated by a threshold cycle (CT) value. The detection limit of the assay was 1 CFU equivalent/PCR (Table 1). This corresponds to 100 CFU equivalents/ml of spiked PCs by the MagNA Pure method and to 10 CFU equivalents/ml with the NucliSens extraction kit. This difference is due to the starting volumes of the clinical samples used to extract DNA.
|
View this table: [in a new window] |
TABLE 1. Detection limit of real-time PCR assay performed with DNA isolated from PCs (spiked with E. coli) using either MagNA Pure or NucliSens extraction procedure
|
|
View this table: [in a new window] |
TABLE 2. Detection limit of assay with DNA extracted from a pure culture of E. coli and serially diluteda
|
Ultrafiltration. Before the addition of template DNA, the PCR mixture was filtered with an Amicon Microcon YM-100 centrifugal filter device (Millipore Corp.) as described by Yang et al. (16). The PCR mixture was passed through the YM-100 filter unit at 100 x g for 30 min.
DNase I treatment. DNase I (Amersham Pharmacia Biotech) (1 U of activity of this nonspecific endonuclease causes an increase in absorbance at 260 nm of 0.001/min/ml at 25°C with DNA as a substrate) was added to the PCR mixture (0.2 U/PCR) without template DNA. The solution was incubated at 37°C for 10 min, followed by heat denaturation at 65°C for 15 min. After this treatment, template DNA was added and the PCR was carried out.
The PCR performed on DNA obtained by either of the two isolation methods described in this paper was very sensitive, and as little as 1 CFU equivalent/reaction mixture could be detected. DNA extraction by the NucliSens method, however, requires a 10-fold larger volume of PCs than the MagNA Pure method: 2,000 instead of 200 µl. The extraction methods also differ in operating time: with the MagNA Pure LC instrument, results can be obtained within 4 h, while the NucliSens extraction kit requires 6 h.
Digestion of the PCR mixture with Sau3AI reduced the amplification signal of the NTC by two PCR cycles (Table 2). Amplification of the reaction mixtures containing template DNA increased accordingly, with one or two PCR cycles, while 1 CFU equivalent/reaction was still detectable.
Filtration of the PCR mixture through a YM-100 filtration unit resulted in an increase of the CT of the NTC to 40, which indicated that contaminating DNA was eliminated. Filtration of the PCR mixture before the addition of template DNA, however, also reduced the sensitivity of the assay (Table 2).
Pretreatment of the PCR mixtures with DNase I led to an unexpected decrease in the CT values of all PCRs, including that of the NTC (Table 2).
Similar results were found when PCR assays were performed with DNA isolated from spiked PCs (Table 3).
|
View this table: [in a new window] |
TABLE 3. Detection limit of assay with DNA extracted from PCs spiked with E. coli DNA without treatment and pretreated by Sau3AI, ultrafiltration, and DNase I
|
Digestion with Sau3AI proved to be effective in reducing contamination of the PCR mixture, as shown by the increase of the mean CT of the NTC. In the case of pretreatment with Sau3AI, the detection limit remained 1 CFU equivalent/PCR.
Following the prefiltration procedure, a mean CT of 40 was generated for the NTC. However, the sensitivity of the assay performed with DNA isolated from spiked PCs was reduced to 30 CFU equivalents/PCR. Thus, Sau3AI seems to be effective, especially when detection of only a few molecules of a target DNA sequence is required. When a detection limit of <10 CFU equivalents/reaction is not needed, prefiltration of the PCR mixture seems to be more appropriate.
Both methods can be simply integrated into the PCR procedure to overcome the problem of contaminating DNA. Pretreatment with Sau3AI extends the assay by 50 min, whereas the prefiltration step prolongs the PCR by 30 min. Pretreatment with DNase I resulted in an unexplainable decrease in the CT values of all PCRs. This nonspecific endonuclease cleaves both DNA strands. During single-strand digestions, DNase I causes gaps and nicks that can be repaired by DNA polymerase. Possibly, this process makes the target sequence more accessible and the amplification of contaminating DNA more efficient. As a result a decrease in the CT values of all PCRs occurred. Since the results of this pretreatment were not consistent, the use of this enzyme to reduce contaminating DNA is not favorable.
In summary, real-time PCR assay in combination with the automated MagNA Pure DNA extraction method meets the requirements for pretransfusion screening of PCs: the assay takes only 4 h to be completed and has the capability to detect very small numbers of bacteria.
When contaminating DNA is a limitation, digestion of the PCR mixture with Sau3AI can be used to remove contaminating DNA without affecting the sensitivity of the assay.
Before this assay can be implemented as a tool to screen PCs for bacterial contamination, further validation studies are needed.
We thank Theo Cuypers and Hans Zaaijer for making their laboratories available to perform the experiments, Marco Koppelman for technical assistance, and Pieter van der Meer and Ruby Pietersz for critical reading of the manuscript.
|
|
|---|
This article has been cited by other articles:
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Copyright © 2009 by the American Society for Microbiology. For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»